1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Hualan Biological Engineering Inc.
  6. Company
    002007   CNE000001JN8

HUALAN BIOLOGICAL ENGINEERING INC.

(002007)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Hualan Biological Engineering, Inc. specializes in the research, development, manufacturing and marketing of biological and sanguine products and vaccines. The group's products include immunoglobulin for intravenous injections, lyophilized surgical fibrin, lyophilized thrombin for external use, vaccines against cold, etc.

Number of employees : 2 927 people.
Sales per Business
20202021Delta
Vaccine2 420.9148.2%1 824.6141.1% -24.63%
Human Albumin956.7719%1 011.0722.8% +5.68%
Other Blood Products810.3516.1%877.8119.8% +8.33%
Intravenous C824.1016.4%708.9016% -13.98%
Other11.080.2%13.810.3% +24.64%
CNY in Million
Sales per region
2021
China4 429.2899.8%
Abroad6.920.2%
CNY in Million
Managers
Name Title Age Since
Bei Fan General Manager & Director 49 2022
Jun Min Xie Chief Financial Officer & Board Secretary 54 2013
Yuan Cheng Lou Securities Representative 37 2020
Bao Xian Zhang Director & Deputy General Manager 50 2022
Xiao Wei Ma Executive Deputy General Manager 53 2022
Yan Chao Wang Head-Human Resources 32 -
Members of the board
Name Title Age Since
Kang An Chairman 72 -
Chao Yuan Ma Chairman-Supervisory Board 37 2019
Yun Long Wang Independent Director 59 2020
Wan Li Liu, Dr. Independent Director 40 2020
Zhi Guo Su, Dr. Independent Director 67 2022
Bei Fan General Manager & Director 49 2022
Bao Xian Zhang Director & Deputy General Manager 50 2022
Ruo Wen Pan Director 53 2022
Lin Lin Cai Member-Supervisory Board 35 2017
Yan Chao Wang Head-Human Resources 32 -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,824,366,726 960,634,274 52.7% 897,750 0.0% 52.7%
Shareholders
NameEquities%
Kang An 596,597,488 38.0%
E Fund Management Co., Ltd. 63,304,315 4.03%
China Securities Finance Corp. Ltd. 54,229,697 3.45%
First Sentier Investors (Australia) IM Ltd. 26,140,727 1.66%
China Investment Corp. (Investment Management) 20,825,064 1.32%
China Merchants Fund Management Co., Ltd. 19,665,822 1.25%
GF Fund Management Co., Ltd. 18,953,887 1.21%
JPMorgan Asset Management (Asia Pacific) Ltd. 18,323,693 1.17%
Yongkang Shengkang Enterprise Management Consulting Ctr LP 13,502,045 0.86%
Zhong Ou Asset Management Co., Ltd 10,326,871 0.66%
Holdings
NameEquities%Valuation
HUALAN BIOLOGICAL BACTERIN DOM SH 270,000,000 73.7% 1,684,270,800 USD
Markets and indexes
- SME Board
- SZSE 100 /
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  002007.SZ
- Datastream Code :  
Company contact information
Hualan Biological Engineering, Inc.
1 Hualan Avenue
CN-HA 453003 Xinxiang, Henan

Phone : +86 0373 3559991
Fax :
web site : http://www.hualanbio.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Hualan Biological Engineering Inc.
Sector Pharmaceuticals
1st jan.Capi. (M$)
HUALAN BIOLOGICAL ENGINEERING INC.-33.63%5 236